CARM
Carisma Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−12.50%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $4.7M
Latest reported
- Last report date
- Nov 12, 2025
- EPS actual
- $1.07
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -46.7%
- Revenue beats (12Q)
- 4
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 12, 2025 | — | $1.07 | — | — |
| Aug 7, 2025 | -$0.12 | -$0.12 | In line | — |
| Mar 31, 2025 | -$0.16 | -$0.42 | Miss -162.50% | $3.7M |
| Nov 7, 2024 | -$0.31 | -$0.31 | In line | $3.4M |
| May 9, 2024 | -$0.37 | -$0.46 | Miss -24.32% | $3.4M |
| Nov 9, 2023 | -$0.60 | -$0.53 | Beat 11.67% | $3.8M |
| Aug 10, 2023 | -$0.66 | -$0.49 | Beat 25.76% | $3.6M |
| May 11, 2023 | -$0.89 | -$1.93 | Miss -116.85% | $3.2M |
| Feb 28, 2023 | -$2.20 | -$0.80 | Beat 63.64% | $3.7M |
| Feb 28, 2022 | -$1.47 | $0.80 | Beat 154.42% | $20.0M |
| Mar 15, 2021 | -$2.13 | -$2.20 | Miss -3.29% | $0.01 |
| Mar 16, 2020 | -$1.67 | -$6.40 | Miss -283.23% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026